Sri Lankan AI Medical Device JENDO Successfully Piloted in Bahrain

A Sri Lankan Innovation Making Global Impact

A Sri Lankan-developed medical innovation, JENDO, has reached an important milestone with its successful pilot deployment in Bahrain. The AI-powered device, designed for non-invasive early detection of cardiovascular conditions, was tested at the King Hamad American Mission Hospital, marking a significant step toward international validation and adoption.

Advanced Technology for Preventive Screening

Developed by engineer Keerthi Kodithuwakku and his team, JENDO leverages advanced physiological signal analysis to enable preventive screening. By focusing on early detection, the system aims to reduce the risks associated with undiagnosed cardiovascular diseases and support timely medical intervention.

Demonstrating Global Potential

The pilot in Bahrain highlights the growing global relevance of Sri Lankan health technology innovations and demonstrates the potential for scalable, AI-driven solutions in modern healthcare. With its non-invasive approach and emphasis on accessibility, JENDO represents a shift toward more proactive and patient-friendly diagnostic methods.

Contributing to Global Healthcare Innovation

This achievement reflects not only technological progress but also the expanding footprint of Sri Lankan innovation on the global stage, reinforcing the country's potential to contribute meaningfully to the future of healthcare.